Webinar - Online
This webinar is intended for pharmaceutical, biotechnology, and medical device companies, in addition to clinical research organizations and academic institutions
Not too long ago, Oracle AERS was the most widely-used adverse event report system. However, with the acquisition of Relsys and its safety and pharmacovigilance system in 2009, Argus Safety quickly became the go-to software for most life sciences companies. Its capabilities and comprehensiveness simply were, and continues to be, unmatched.
Companies currently using Oracle AERS have expressed interest in moving to Argus Safety, but want to know more before making the jump. This webinar is meant to do just that – answer your common questions.
Please join BioPharm’s Dr. Rodney Lemery, VP of safety and pharmacovigilance, for a free one-hour webinar in which he will:
Compare Argus Safety to AERS
Cover the options of effectively migrating to Argus Safety
Speaker: Dr. Rodney Lemery
Organization: BioPharm Systems
Migrating from Oracle AERS to Argus Safety: The Reasons for the Move
Thu, Jun 12, 2014 (11:00 AM - 12:00 AM EDT)
Webinar - Online
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
